SCHEMBL982729

SCHEMBL982729

C=CC(OC(=O)O)C(C=C)OC(=O)O

nearest known ligand 0.35

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.35
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
BLM P54132 1/20 0.31
SLC6A3 Q01959 1/20 0.31
MEN1 O00255 1/20 0.31
CYP2D6 P10635 1/20 0.31
TSHR P16473 1/20 0.31
NFKB1 P19838 1/20 0.31
CYP2C19 P33261 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9277707 0.85 HCAR2 (0.32) TSHR
SCHEMBL10842812 0.85
SCHEMBL10181078 0.83
SCHEMBL981827 0.83 HCAR2 (0.31) TSHR
SCHEMBL16353963 0.83 HCAR2 (0.31) TSHR
SCHEMBL980469 0.78 TSHR (0.32) TSHR
SCHEMBL28059975 0.77 LMNA (0.35) LMNASLC6A2SLC6A4BLMSLC6A3
SCHEMBL10180352 0.75 CHRM1 (0.34) SLC6A3TSHR
SCHEMBL13454198 0.74 TSHR (0.46) BLMTSHR
SCHEMBL643455 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 349 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3940845-B1 ELECTROLYTE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME NINGDE AMPEREX TECHNOLOGY LTD (CN) 2025-01-22 EP claimed
US-12125983-B2 Electrolyte and electrochemical device including the same NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2024-10-22 US claimed
EP-3940845-A1 ELECTROLYTE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME NingDe Amperex Technology Limited (CN) 2022-01-19 EP claimed
EP-1892789-B1 LITHIUM SECONDARY BATTERY MITSUBISHI CHEM CORP (JP) 2018-02-28 EP claimed
US-20110014504-A1 LITHIUM SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2011-01-20 US claimed
US-20080311478-A1 Lithium Secondary Battery MITSUBISHI CHEMICAL CORPORATION (JP) 2008-12-18 US claimed
EP-1892789-A1 LITHIUM SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2008-02-27 EP claimed
EP-4148851-B1 ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE NINGDE AMPEREX TECHNOLOGY LTD (CN) 2026-05-13 EP disclosed
US-20260094882-A1 LITHIUM-ION BATTERY ZHUHAI COSMX BATTERY CO., LTD. (CN) 2026-04-02 US disclosed
US-12537184-B2 Electrochemical device and electronic device NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2026-01-27 US disclosed
US-20250372707-A1 Non-Aqueous Electrolyte and Lithium Secondary Battery Using the Same LG ENERGY SOLUTION, LTD. (KR) 2025-12-04 US disclosed
EP-4657604-A2 ELECTROLYTE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME Ningde Amperex Technology Limited (CN) 2025-12-03 EP disclosed
EP-4404324-B1 ELECTROLYTE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME NINGDE AMPEREX TECHNOLOGY LTD (CN) 2025-11-19 EP disclosed
US-20130244122-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME ONUKI MASAMICHI (JP) 2013-09-19 US disclosed
US-20120219866-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2012-08-30 US disclosed
EP-2475041-A1 NON-AQUEOUS ELECTROLYTIC SOLUTION, AND NON-AQUEOUS ELECTROLYTE BATTERY COMPRISING SAME Mitsubishi Chemical Corporation (JP) 2012-07-11 EP disclosed
US-20110014504-A1 LITHIUM SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2011-01-20 US disclosed
US-20090253044-A1 Nonaqueous Electrolyte and Lithium ion Secondary Battery Using Same MITSUI CHEMICALS, INC. (JP) 2009-10-08 US disclosed
US-20080311478-A1 Lithium Secondary Battery MITSUBISHI CHEMICAL CORPORATION (JP) 2008-12-18 US disclosed
EP-1892789-A1 LITHIUM SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2008-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12537184-B2 Electrochemical device and electronic device LBR, LAMTOR3, CACNA2D1 LMNA 710/4885SLC6A2 2522/4885SLC6A4 2694/4885
US-20260094882-A1 LITHIUM-ION BATTERY LBR, SLC9A2, SLC8A1 LMNA 90/4885SLC6A2 30/4885SLC6A4 267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.